ANDERA PARTNERS

Fundamental diversified ★Signal healthcare specialist (100%) CIK 1757283
Long book
$176.9M
Q1 2026
Positions
7
Top-10 weight
100%
concentration
Last quarter
+1.8%
SPY +14.8%
Turnover
29%
of book per quarter

Strategy in plain words

auto-generated from filings

ANDERA PARTNERS is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $176.9M US long book across 7 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: KESTRA MEDICAL TECHNOLOGIES, EVOMMUNE INC, MINERALYS THERAPEUTICS INC, AGOMAB THERAPEUTICS NV, INVENTIVA SA - ADR.

We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q4 2025
-11.6%
Q1 2026
+1.8%

Sector allocation

Healthcare
100%

Long book by quarter

$176.6M
Q4 2025
$176.9M
Q1 2026

What does ANDERA own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
KMTS KESTRA MEDICAL TECHNOLOGIESHealthcare2.7M$53.7M30.4%+6.1%
EVMN EVOMMUNE INCHealthcare1.9M$43.6M24.7%Held
MLYS MINERALYS THERAPEUTICS INCHealthcare1.6M$43.1M24.4%Held
NYXH NYXOAH SAHealthcare522.1K$1.5M0.9%New

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 11, 20267$176.9M canonicalSEC ↗
Q4 202513F-HRFeb 17, 20265$176.6M canonicalSEC ↗

Similar funds

LILLY ENDOWMENT INCBAKER BROS. ADVISORS LPINVESTOR ABCarlyle Group Inc.GREENLEAF TRUSTAvoro Capital Advisors LLCRTW INVESTMENTS, LPRA CAPITAL MANAGEMENT, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.Simplify Asset Management Inc.PERCEPTIVE ADVISORS LLCParadigm Biocapital Advisors LP